Aravive, Inc. Net Change in Cash
Aravive, Inc. reported Net Change in Cash of -$45.19 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2023-11-09
- Aravive, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$17.75M, a 377.33% decline year-over-year.
- Aravive, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was $6.40M, a 64.72% decline year-over-year.
- Aravive, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-03-31 was $18.14M.
- Aravive, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2020-03-31 was -$4.43M.
- Aravive, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$5.72M.
- Aravive, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was -$1.12M.
- Aravive, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was -$4.59M, a 156.14% decline from fiscal 2019.
- Aravive, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2019 was $8.17M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$45.19M 10-Q · filed 2023-11-09 | |||
| 2023-06-30 | -$35.38M 10-Q · filed 2023-08-21 | |||
| 2023-03-31 | -$17.75M 10-Q · filed 2023-05-10 | |||
| 2022-12-31 | -$5.72M 10-K · filed 2023-03-15 | |||
| 2022-09-30 | -$31.52M 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | -$12.59M 10-Q · filed 2023-08-21 | |||
| 2022-03-31 | $6.40M 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | -$1.12M 10-K · filed 2023-03-15 | |||
| 2021-09-30 | $6.97M 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | $14.90M 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | $18.14M 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | -$4.59M 10-K · filed 2022-03-31 | |||
| 2020-09-30 | -$11.16M 10-Q · filed 2021-10-28 | |||
| 2020-06-30 | -$5.07M 10-Q · filed 2021-08-05 | |||
| 2020-03-31 | -$4.43M 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $8.17M 10-K · filed 2021-03-16 | |||
| 2019-09-30 | -$11.99M 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | -$8.60M 10-Q · filed 2020-08-03 | |||
| 2019-03-31 | -$1.40M 10-Q · filed 2020-05-06 | |||
| 2018-12-31 | -$24.14M 10-K · filed 2020-03-27 | |||
| 2018-09-30 | -$18.53M 10-Q · filed 2019-11-07 | |||
| 2018-06-30 | -$13.37M 10-Q · filed 2019-08-07 | |||
| 2018-03-31 | -$6.46M 10-Q · filed 2019-05-08 | |||
| 2017-12-31 | -$117.62M 10-K · filed 2019-03-15 | |||
| 2017-09-30 | -$79.99M 10-Q · filed 2018-11-09 | |||
| 2017-06-30 | -$55.42M 10-Q · filed 2018-08-08 | |||
| 2017-03-31 | -$33.69M 10-Q · filed 2018-05-08 |